Produced by Araxis Merge on 3/28/2018 4:50:47 PM Central Daylight Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | Wed Mar 28 21:50:46 2018 UTC | ||
| 2 | PSD_3.0_82_Feb_2018.zip | PSD_3.0_82 - Requirements_User Story Specification.docx | Wed Mar 28 14:26:35 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 0 | 0 |
| Changed | 0 | 0 |
| Inserted | 1 | 81 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | Requiremen ts Specifi cation | |||||
| 2 | ||||||
| 3 | ||||||
| 4 | ||||||
| 5 | ||||||
| 6 | Project Co ntrolled_S ubstances (RM) Prepa red by EPI P Configur ation Mana ger Februa ry 7, 2018 , 3:14:43 PM CST | |||||
| 7 | ||||||
| 8 | Table of C ontents | |||||
| 9 | Introducti on3 | |||||
| 10 | NSR 201609 11 - EPIC 824660: Al low Pharma cy Technic ians to ru n NAOU Usa ge Report. 3 | |||||
| 11 | Attributes 3 | |||||
| 12 | Artifact C ontent4 | |||||
| 13 | Comments4 | |||||
| 14 | ||||||
| 15 | ||||||
| 16 | ||||||
| 17 | Introducti on | |||||
| 18 | ||||||
| 19 | The purpos e of this document i s to defin e the requ irements. | |||||
| 20 | NSR 201609 11 - EPIC 824660: Al low Pharma cy Technic ians to ru n NAOU Usa ge Report | |||||
| 21 | ||||||
| 22 | For VA Pha rmacy tech nicians, w ho need to be able t o run the NAOU Usage Report, a process t hat allows technicia ns to run the report that ensu res either licensed pharmacist s holding the PSJ RP HARM key o r technici ans holdin g the PSD TECH ADV k ey have ac cess. Unli ke our cur rent proce ss which r estricts a ccess to o nly licens ed pharmac ists holdi ng the PSJ RPHARM ke y, our pro cess expan ds usage t o technici ans who ne ed to be a ble to run this repo rt in orde r to gener ate data f or the con trolled su bstance in spection p rocess wit hout havin g to give them inapp ropriate a ccess to o ther optio ns via the PSJ RPHAR M key and in order t o promote efficiency of staff utilizatio n in minim izing the wait time for contro lled subst ance inspe ctors to h ave the in formation they requi re to per form the r eviews in the most t imely mann er. | |||||
| 23 | Attributes | |||||
| 24 | ||||||
| 25 | AttributeV alue | |||||
| 26 | ||||||
| 27 | ||||||
| 28 | ||||||
| 29 | ||||||
| 30 | Artifact T ype | |||||
| 31 | Business U ser Story | |||||
| 32 | ||||||
| 33 | ||||||
| 34 | ||||||
| 35 | ||||||
| 36 | ||||||
| 37 | Acceptance Criteria | |||||
| 38 | In Scope: Work neces sary to en sure the l ocal solut ion runs a t all faci lities. | |||||
| 39 | ||||||
| 40 | ||||||
| 41 | ||||||
| 42 | Out of Sco pe:• New f unctional enhancemen ts that ar e not requ ired as pa rt of ensu ring the s olution ru ns success fully at o ther facil ities. • O n/Off swit ch not nee ded becaus e PSD TECH ADV key h olders sho uld be abl e to run t his report . | |||||
| 43 | ||||||
| 44 | ||||||
| 45 | ||||||
| 46 | ||||||
| 47 | TestableTB D | |||||
| 48 | ||||||
| 49 | ||||||
| 50 | ||||||
| 51 | WhoBusines s Architec t | |||||
| 52 | ||||||
| 53 | ||||||
| 54 | ||||||
| 55 | Identifier 944995 | |||||
| 56 | ||||||
| 57 | ||||||
| 58 | ||||||
| 59 | ||||||
| 60 | Business P riority | |||||
| 61 | Must | |||||
| 62 | ||||||
| 63 | ||||||
| 64 | ||||||
| 65 | ||||||
| 66 | StatusAppr oved | |||||
| 67 | Version1 | |||||
| 68 | ||||||
| 69 | ||||||
| 70 | ||||||
| 71 | ||||||
| 72 | ||||||
| 73 | ||||||
| 74 | Artifact C ontent | |||||
| 75 | ||||||
| 76 | For VA Pha rmacy tech nicians, w ho need to be able t o run the NAOU Usage Report, a process t hat allows technicia ns to run the report that ensu res either licensed pharmacist s holding the PSJ RP HARM key o r technici ans holdin g the PSD TECH ADV k ey have ac cess. Unli ke our cur rent proce ss which r estricts a ccess to o nly licens ed pharmac ists holdi ng the PSJ RPHARM ke y, our pro cess expan ds usage t o technici ans who ne ed to be a ble to run this repo rt in orde r to gener ate data f or the con trolled su bstance in spection p rocess wit hout havin g to give them inapp ropriate a ccess to o ther optio ns via the PSJ RPHAR M key and in order t o promote efficiency of staff utilizatio n in minim izing the wait time for contro lled subst ance inspe ctors to h ave the in formation they requi re to per form the r eviews in the most t imely mann er. | |||||
| 77 | ||||||
| 78 | ||||||
| 79 | Comments | |||||
| 80 | ||||||
| 81 | none |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.